Abstract:Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC We have previously developed the genetically-modified Salmonella typhimurium A1-R (A1-R) strain that selectively targets tumors and demonstrated its efficacy for various types of cancer cell lines in nude mouse models. The aim of this study is to determine the efficacy A1-R treatment for human-patient pancreatic tumorgrafts. Pancreatic-cancer-patient tumor specimens were initially established subcutaneously in NOD/SCID mice immediately after surgery. The patient tumors were then harvested from NOD/SCID mice and passed orthotopically in transgenic nude mice, expressing fluorescent protein in order for the tumors to acquire fluorescent stroma for imaging. After confirmation of tumor growth by fluorescence imaging, the nude mice were treated in the following groups: (1) 5-fluorouracil (5FU) (10 mg/kg, ip); (2) cisplatin (CDDP) (10 mg/kg, ip); (3) gemcitabine (GEM) (150 mg/kg, ip); (4) A1-R (A1-R) (1.5x108 cfu/body, ip); and (5) PBS (vehicle/control) (ip). Control, 5FU, CDDP, GEM and A1-R injections were performed on a weekly basis from day-21 after tumor implantation for 4 weeks. Animals were sacrificed at 7 weeks, and tumors were harvested for analysis. Each treatment arm involved 5 tumor-bearing mice. No significant effects on body weight, morbidity, or severe toxicities were observed in any treatment arm. The tumor weight of each group was as follows: (1) 5FU, 0.044 ± 0.027g; (2) CDDP, 0.04 ± 0.032g; (3) GEM, 0.058 ± 0.051g; (4) A1-R, 0.106 ± 0.038g; and (5) PBS, 0.258 ± 0.209g. S. typhimurium A1-R treatment significantly reduced the tumor weight compared to control treatment (p = 0.011), as did the other treatments including 5FU (p = 0.005), CDDP (p = 0.004), and GEM (p = 0.001). S. typhimurium A1-R treatment was effective for human pancreatic tumorgrafts and could be a promising therapy for human pancreatic cancer. Citation Format: Ming Zhao, Matthew H.G. Katz, Jason B. Fleming, Atsushi Suetsugu, Yong Zhang, Ali Maawy, Takashi Chishima, Kuniya Tanaka, Michael Bouvet, Yukihiko Hiroshima, Itaru Endo, Robert M. Hoffman. Efficacy of Salmonella typhimurium A1-R treatment on human patient pancreatic tumorgrafts. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3317. doi:10.1158/1538-7445.AM2013-3317

Efficacy of tumor-targeting Salmonella typhimurium A1-R on nude mouse models of metastatic and disseminated human ovarian cancer.

Tumor-Targeting Salmonella Typhimurium A1-R Inhibits Peritoneal Dissemination Of Ovarian Cancer And Prolongs Survival Of The Tumor-Bearing Nude Mice

Intraperitoneal Administration of Tumor-Targeting Salmonella Typhimurium A1-R Inhibits Disseminated Human Ovarian Cancer and Extends Survival in Nude Mice

The Efficacy Of Tumor-Targeting Salmonella Typhimurium A1-R On Bone Metastasis

Therapeutic Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R on Human Colorectal Cancer Liver Metastasis in Orthotopic Nude-Mouse Models.

Tumor-targeting Salmonella Typhimurium A1-R Prevents Experimental Human Breast Cancer Bone Metastasis in Nude Mice

Efficacy Of Tumor-Targeting Salmonella Typhimurium A1-R On Highly Metastatic Human Pancreatic Cancer In Nude Mice

Efficacy Against Lung Metastasis with a Tumor-Targeting Mutant of Salmonella Typhimurium in Immunocompetent Mice.

Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models

Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.

Toxicology and Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R Compared to VNP 20009 in a Syngeneic Mouse Tumor Model in Immunocompetent Mice

Tumor-Targeting Salmonella Typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models

Abstract 2802: Salmonella typhimurium A1-R inhibits brain metastasis in an orthotropic breast cancer nude-mouse model.

Inhibition of Spontaneous and Experimental Lung Metastasis of Soft-Tissue Sarcoma by Tumor-Targeting Salmonella Typhimurium A1-R

High-Efficacy Targeting of Colon-Cancer Liver Metastasis with Salmonella Typhimurium A1-R Via Intra-Portal-Vein Injection in Orthotopic Nude-Mouse Models

Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R in Combination with Anti-Angiogenesis Therapy on A Pancreatic Cancer Patient-Derived Orthotopic Xenograft (pdox) and Cell-Line Mouse Models

Tumor-Targeting Salmonella Typhimurium A1-R Efficacy On Colon Cancer Liver Metastasis Alone And In Combination With Fluorescence-Guided Surgery

Effect of Salmonella Typhimurium A1-R on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) in Nude Mice.

Abstract 3317: Efficacy of Salmonella typhimurium A1-R treatment on human patient pancreatic tumorgrafts.

Salmonella Typhimurium A1-R Inhibits Surgically Induced Breast Cancer Metastasis

Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture.